BioSpace News Archive

Press Releases

Johnson & Johnson Announces Quarterly Dividend for First Quarter 2025

January 2, 2025
·
1 min read
Press Releases

Scholar Rock to Present at the 43rd Annual J.P. Morgan Healthcare Conference

January 2, 2025
·
2 min read
Press Releases

Star Therapeutics to Present at 43rd Annual J.P. Morgan Healthcare Conference

January 2, 2025
·
1 min read
Press Releases

Abbott Hosts Conference Call for Fourth-Quarter Earnings

January 2, 2025
·
1 min read
Press Releases

Walgreens Boots Alliance Adjusts Fiscal 2025 First Quarter Earnings Announcement to be Held on January 10

January 2, 2025
·
1 min read
Press Releases

Telo Genomics Closes Oversubscribed $2.5 Million Private Placement

January 2, 2025
·
5 min read
Press Releases

Canadian Company Moss Genomics Announces Agreement to Acquire Ethereum, Appoints Jack Liu as CEO and Director, Private Placement and Option Grant

January 2, 2025
·
6 min read
Press Releases

MustGrow Biologics Completes Acquisition of NexusBioAg

January 2, 2025
·
6 min read
Press Releases

Hemostemix’s Social Media Awareness of “Your Fountain of Youth"(TM) Regenerative Medicine Treatments Is Gaining Traction

Hemostemix is revolutionizing how individuals think about their own regenerative medicine treatments. With social media, the company is educating individuals about treatments and advancements.

January 2, 2025
·
6 min read
Press Releases

NervGen Completes Enrollment in Chronic Cohort of its Phase 1b/2a Clinical Trial of NVG-291 in Spinal Cord Injury

Topline data from the chronic cohort is expected in Q2 2025 Institutional Review Board (IRB) protocol amendment changes approved, and screening has been initiated for subacute cohortThis news release constitutes a “designated news release” for the purposes of NervGen’s prospectus supplement dated December 19, 2024 to its short form base shelf prospectus dated November 25, 2024.

January 2, 2025
·
7 min read